Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153371 · ClinicalTrials.gov registry record
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 180
- Enrollment target
NCT03153371 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 180 participants.
The verdict
NCT03153371 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
This study attempts to identify two types of AD by using clinical and cognitive tasks and brain imaging. The subtypes of AD are separated into a "typical" group (memory loss) and a "variant" group (language, visuospatial, and other cognitive difficulties). Performance on the clinical tasks and brain imaging will be compared among the young-onset Alzheimer's disease group, a late-onset Alzheimer's disease group, and a control group.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2016-04-04 |
| Est. Completion | 2021-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03153371
The ClinicalTrials.gov registry entry for NCT03153371 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03153371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03153371 about?
NCT03153371 is a clinical study titled "Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks". This study attempts to identify two types of AD by using clinical and cognitive tasks and brain imaging. The subtypes of AD are separated into a "typical" group (memory loss) and a "variant" group (language, visuospatial, and other cognitive difficulties). Performance on the clinical tasks and brain...
What is the current status of trial NCT03153371?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2016-04-04. Estimated completion is 2021-08-31.
Who is sponsoring clinical trial NCT03153371?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.